A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
about
A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A small molecular agent YL529 ...... ts known antitumor activities.
@ast
A small molecular agent YL529 ...... ts known antitumor activities.
@en
type
label
A small molecular agent YL529 ...... ts known antitumor activities.
@ast
A small molecular agent YL529 ...... ts known antitumor activities.
@en
prefLabel
A small molecular agent YL529 ...... ts known antitumor activities.
@ast
A small molecular agent YL529 ...... ts known antitumor activities.
@en
P2093
P2860
P1433
P1476
A small molecular agent YL529 ...... ts known antitumor activities.
@en
P2093
Chunting Wang
Hongjun Lin
Luoting Yu
Shengyong Yang
Siying Wang
P2860
P2888
P356
10.1186/S12885-015-1451-2
P407
P577
2015-07-18T00:00:00Z
P5875
P6179
1037470618